@smlluesma3.bsky.social
Reposted
It has been a great symposium! Thanks to all participants, looking forward to the next edition!
✨ Good morning from Barcelona!
We’re kicking off the second day of the 2nd VHIO –Fundacion @bbvaenespana.bsky.social Symposium on Cell-Based Therapies in Cancer.
Another round of innovation, science and brilliant minds ahead.
🎥 The event on YT: www.youtube.com/live/MlYp4S8...
#VHIOBBVASymposium
We’re kicking off the second day of the 2nd VHIO –Fundacion @bbvaenespana.bsky.social Symposium on Cell-Based Therapies in Cancer.
Another round of innovation, science and brilliant minds ahead.
🎥 The event on YT: www.youtube.com/live/MlYp4S8...
#VHIOBBVASymposium
2nd VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology DAY 2
YouTube video by Vall d'Hebron Institute of Oncology - VHIO
www.youtube.com
November 15, 2025 at 9:19 PM
It has been a great symposium! Thanks to all participants, looking forward to the next edition!
Reposted
✨ Good morning from Casa de la Convalescència, Barcelona!
🛜 We’re live at the 2nd VHIO - BBVA Foundation Symposium on Cell-Based Therapies in Cancer — two inspiring days ahead filled with innovation, science, and great minds!
🔗 Watch live: youtube.com/live/egVp3sW...
#VHIOBBVASymposium #SOMMVhio
🛜 We’re live at the 2nd VHIO - BBVA Foundation Symposium on Cell-Based Therapies in Cancer — two inspiring days ahead filled with innovation, science, and great minds!
🔗 Watch live: youtube.com/live/egVp3sW...
#VHIOBBVASymposium #SOMMVhio
2nd VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology DAY 1
YouTube video by Vall d'Hebron Institute of Oncology - VHIO
youtube.com
November 13, 2025 at 8:24 AM
✨ Good morning from Casa de la Convalescència, Barcelona!
🛜 We’re live at the 2nd VHIO - BBVA Foundation Symposium on Cell-Based Therapies in Cancer — two inspiring days ahead filled with innovation, science, and great minds!
🔗 Watch live: youtube.com/live/egVp3sW...
#VHIOBBVASymposium #SOMMVhio
🛜 We’re live at the 2nd VHIO - BBVA Foundation Symposium on Cell-Based Therapies in Cancer — two inspiring days ahead filled with innovation, science, and great minds!
🔗 Watch live: youtube.com/live/egVp3sW...
#VHIOBBVASymposium #SOMMVhio
It has been a great symposium! Thanks to all participants, looking forward to the next edition!
✨ Good morning from Barcelona!
We’re kicking off the second day of the 2nd VHIO –Fundacion @bbvaenespana.bsky.social Symposium on Cell-Based Therapies in Cancer.
Another round of innovation, science and brilliant minds ahead.
🎥 The event on YT: www.youtube.com/live/MlYp4S8...
#VHIOBBVASymposium
We’re kicking off the second day of the 2nd VHIO –Fundacion @bbvaenespana.bsky.social Symposium on Cell-Based Therapies in Cancer.
Another round of innovation, science and brilliant minds ahead.
🎥 The event on YT: www.youtube.com/live/MlYp4S8...
#VHIOBBVASymposium
2nd VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology DAY 2
YouTube video by Vall d'Hebron Institute of Oncology - VHIO
www.youtube.com
November 15, 2025 at 9:19 PM
It has been a great symposium! Thanks to all participants, looking forward to the next edition!
Reposted
We joined forces across Europe to map, connect & accelerate the development of ATMPs — gene, cell and tissue-based therapies that could transform patient care.
We make ATMP innovation faster, safer and more accessible for everyone.
👉 join4atmp.eu
#JOIN4ATMP #ATMP #HorizonEurope #HealthInnovation
We make ATMP innovation faster, safer and more accessible for everyone.
👉 join4atmp.eu
#JOIN4ATMP #ATMP #HorizonEurope #HealthInnovation
October 24, 2025 at 10:13 AM
We joined forces across Europe to map, connect & accelerate the development of ATMPs — gene, cell and tissue-based therapies that could transform patient care.
We make ATMP innovation faster, safer and more accessible for everyone.
👉 join4atmp.eu
#JOIN4ATMP #ATMP #HorizonEurope #HealthInnovation
We make ATMP innovation faster, safer and more accessible for everyone.
👉 join4atmp.eu
#JOIN4ATMP #ATMP #HorizonEurope #HealthInnovation
Very happy to have participated in the Summer School in Translational
Cancer Research 2025, from 5 to 10 October, 2025, discussing about:
"Reviving TIL-ACT: Rediscovering an effective melanoma treatment after more than two decades"
#CCESumSchool25; @vhio.bsky.social
lnkd.in/d-7tuR88
Cancer Research 2025, from 5 to 10 October, 2025, discussing about:
"Reviving TIL-ACT: Rediscovering an effective melanoma treatment after more than two decades"
#CCESumSchool25; @vhio.bsky.social
lnkd.in/d-7tuR88
October 13, 2025 at 9:37 AM
Very happy to have participated in the Summer School in Translational
Cancer Research 2025, from 5 to 10 October, 2025, discussing about:
"Reviving TIL-ACT: Rediscovering an effective melanoma treatment after more than two decades"
#CCESumSchool25; @vhio.bsky.social
lnkd.in/d-7tuR88
Cancer Research 2025, from 5 to 10 October, 2025, discussing about:
"Reviving TIL-ACT: Rediscovering an effective melanoma treatment after more than two decades"
#CCESumSchool25; @vhio.bsky.social
lnkd.in/d-7tuR88
Thanks for the invitation to @caixaresearch.bsky.social ! It was a great opportunity to discuss with great researchers!
1/ 🚀Advanced therapies hold immense promise—yet turning breakthroughs into real treatments requires more than innovation.
At #HealthResearchMeeting, Silvia Martín-Lluesma (@vhio.bsky.social) explored the long road from lab to patient, and the hurdles to make therapies accessible for all.👇
At #HealthResearchMeeting, Silvia Martín-Lluesma (@vhio.bsky.social) explored the long road from lab to patient, and the hurdles to make therapies accessible for all.👇
October 3, 2025 at 5:18 PM
Thanks for the invitation to @caixaresearch.bsky.social ! It was a great opportunity to discuss with great researchers!
Reposted
Es hora de pasar a la acción, el tantas veces anunciado Museo Cajal debe ser una realidad ya. El más grande de nuestros sabios lo merece desde hace mucho tiempo. Subscribo esta carta preparada por muchos colegas y amigos que publica hoy @elpais.com ⬇️
elpais.com/ciencia/2025...
elpais.com/ciencia/2025...
Un grito por el Museo Cajal
Científicos y familiares de Santiago Ramón y Cajal piden la creación urgente de un Museo Nacional dedicado al padre de la neurociencia, como prometieron el presidente Pedro Sánchez y la ministra Diana...
elpais.com
May 31, 2025 at 4:40 AM
Es hora de pasar a la acción, el tantas veces anunciado Museo Cajal debe ser una realidad ya. El más grande de nuestros sabios lo merece desde hace mucho tiempo. Subscribo esta carta preparada por muchos colegas y amigos que publica hoy @elpais.com ⬇️
elpais.com/ciencia/2025...
elpais.com/ciencia/2025...
Reposted
La unidad de cáncer pediátrico del CNIO ha tratado a una niña con la enfermedad rara dermatomiositis anti-MDA5 con una CAR-T
Hospital público La Paz
"Investigar en el CNIO nos ayudará a aplicar lo aprendido a futuros casos" @andresparismu.bsky.social
@mcti.bsky.social
www.cnio.es/noticias/la-...
Hospital público La Paz
"Investigar en el CNIO nos ayudará a aplicar lo aprendido a futuros casos" @andresparismu.bsky.social
@mcti.bsky.social
www.cnio.es/noticias/la-...
La unidad de Cáncer Pediátrico del CNIO trata con éxito en el hospital La Paz una enfermedad rara autoinmune con una terapia CAR-T
La Unidad Mixta de Investigación Clínica de Oncohematología Pediátrica IdiPAZ-CNIO, dirigida por el oncólogo Antonio Pérez Martínez, investiga «para solucionar los problemas que aparecen en la clínica...
www.cnio.es
May 5, 2025 at 6:18 PM
La unidad de cáncer pediátrico del CNIO ha tratado a una niña con la enfermedad rara dermatomiositis anti-MDA5 con una CAR-T
Hospital público La Paz
"Investigar en el CNIO nos ayudará a aplicar lo aprendido a futuros casos" @andresparismu.bsky.social
@mcti.bsky.social
www.cnio.es/noticias/la-...
Hospital público La Paz
"Investigar en el CNIO nos ayudará a aplicar lo aprendido a futuros casos" @andresparismu.bsky.social
@mcti.bsky.social
www.cnio.es/noticias/la-...
Reposted
No estamos calentando. Fuente: svs.gsfc.nasa.gov/5190/
April 20, 2025 at 7:05 AM
No estamos calentando. Fuente: svs.gsfc.nasa.gov/5190/
Have a look into our last publication, a great collaborative effort reviewing TIL-ACT safety, aiming to facilitate access for patients.
pubmed.ncbi.nlm.nih.gov/40210086/
pubmed.ncbi.nlm.nih.gov/40210086/
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis - PubMed
TIL-ACT, a new approved and promising therapy for melanoma patients, presents a distinctive toxicity profile that is currently manageable with supportive care methods, with reported toxicities mainly ...
pubmed.ncbi.nlm.nih.gov
April 18, 2025 at 11:16 PM
Have a look into our last publication, a great collaborative effort reviewing TIL-ACT safety, aiming to facilitate access for patients.
pubmed.ncbi.nlm.nih.gov/40210086/
pubmed.ncbi.nlm.nih.gov/40210086/
Reposted
👩🏻💻 👩🏻⚕️ 🧑🏻🔬 At VHIO, we transform knowledge into health, quality of life, and new opportunities. Working tirelessly against cancer, we believe in the power of what we do
🌐 vhio.net
With: Vall d'Hebron Barcelona Hospital Campus; SOMM Alliance and ICERCA
#oncology #cancer
🌐 vhio.net
With: Vall d'Hebron Barcelona Hospital Campus; SOMM Alliance and ICERCA
#oncology #cancer
November 19, 2024 at 8:53 AM
Reposted
💬 “Si hacemos bien las cosas, se pueden evitar el 30% de los tumores”
Josep Tabernero, director del #VHIO, destaca la importancia de la prevención, la investigación y los recursos para combatir el cáncer 👇
Josep Tabernero, director del #VHIO, destaca la importancia de la prevención, la investigación y los recursos para combatir el cáncer 👇
'Si hacemos bien las cosas, se pueden evitar el 30% de los tumores'
linke.to
April 10, 2025 at 4:31 PM
💬 “Si hacemos bien las cosas, se pueden evitar el 30% de los tumores”
Josep Tabernero, director del #VHIO, destaca la importancia de la prevención, la investigación y los recursos para combatir el cáncer 👇
Josep Tabernero, director del #VHIO, destaca la importancia de la prevención, la investigación y los recursos para combatir el cáncer 👇
Reposted
Announcing the new bioRxiv dashboard widget - it's now easier to when articles have comments, peer reviews, community discussion, media coverage, videos, and automated analyses 1/2 connect.biorxiv.org/news/2025/01...
January 18, 2025 at 1:55 PM
Announcing the new bioRxiv dashboard widget - it's now easier to when articles have comments, peer reviews, community discussion, media coverage, videos, and automated analyses 1/2 connect.biorxiv.org/news/2025/01...
Reposted
Our lab wishes you all a Merry Christmas!
We finish the scientific year at the @irbbarcelona.org Christmas party with the best costume ever!! 🤣🤣🤣
We finish the scientific year at the @irbbarcelona.org Christmas party with the best costume ever!! 🤣🤣🤣
December 24, 2024 at 6:14 PM
Our lab wishes you all a Merry Christmas!
We finish the scientific year at the @irbbarcelona.org Christmas party with the best costume ever!! 🤣🤣🤣
We finish the scientific year at the @irbbarcelona.org Christmas party with the best costume ever!! 🤣🤣🤣
Reposted
⚠️ Gene editing may be considered a misleading term as nowadays we are far beyond "just changing the DNA"!
Here is what we can do!
Want more WeDoCRISPR content?
Follow us on LinkedIN and Check out our YouTube channel: lnkd.in/dPCqParT
#crispr #crisprcas9 #geneediting #geneandcelltherapy
Here is what we can do!
Want more WeDoCRISPR content?
Follow us on LinkedIN and Check out our YouTube channel: lnkd.in/dPCqParT
#crispr #crisprcas9 #geneediting #geneandcelltherapy
December 15, 2024 at 11:27 AM
⚠️ Gene editing may be considered a misleading term as nowadays we are far beyond "just changing the DNA"!
Here is what we can do!
Want more WeDoCRISPR content?
Follow us on LinkedIN and Check out our YouTube channel: lnkd.in/dPCqParT
#crispr #crisprcas9 #geneediting #geneandcelltherapy
Here is what we can do!
Want more WeDoCRISPR content?
Follow us on LinkedIN and Check out our YouTube channel: lnkd.in/dPCqParT
#crispr #crisprcas9 #geneediting #geneandcelltherapy